Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT04649359
Brief Title: MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb

First Submitted : November 6, 2020
First Submitted that Met QC Criteria : November 24, 2020
First Posted : December 2, 2020

Last Update Submitted that Met QC Criteria : April 14, 2022
Last Update Posted : April 18, 2022